Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 18,000 shares at $119.90 ($2.2M) on 2013-07-12, disclosed to the SEC on 2013-07-16.
Scheduled sale ($2.2M) by EVP, Chief Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-28 | $1.1M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |